Literature DB >> 10082492

Diastolic compliance is reduced in obese rabbits.

J F Carroll1, R L Summers, D J Dzielak, K Cockrell, J P Montani, H L Mizelle.   

Abstract

Obesity often leads to symptoms of cardiopulmonary congestion associated with normal systolic but abnormal diastolic function. This study analyzed alterations in passive diastolic compliance in obesity using the rabbit model. New Zealand White rabbits were fed a normal (n=8) or 10% added fat diet (n=8). After 12 weeks, rabbits fed the high fat diet developed obesity (5.34+/-0.11 versus 3.68+/-0. 04 kg, P</=0.05) and left ventricular hypertrophy (1.37+/-0.07 versus 0.98+/-0.03 g dry weight, P</=0.05). Compliance was assessed with the isolated heart preparation by analyzing the passive end-diastolic left ventricular pressure-volume relationship. The pressure-volume relation was fit to an exponential function by regression analysis; results showed that the modulus of stiffness was greater in obese than in lean rabbits (1.21+/-0.16 versus 0. 83+/-0.05, P</=0.05), indicating that diastolic compliance was reduced. Computer simulation analyses suggested that an isolated reduction in diastolic compliance may contribute to elevated cardiac filling pressures and exercise intolerance. These data suggest that diastolic compliance is reduced early in the development of obesity and may be an important component in the reduction of cardiac reserve in obesity.

Entities:  

Mesh:

Year:  1999        PMID: 10082492     DOI: 10.1161/01.hyp.33.3.811

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Central nervous system dysfunction in obesity-induced hypertension.

Authors:  Geoffrey A Head; Kyungjoon Lim; Benjamin Barzel; Sandra L Burke; Pamela J Davern
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 2.  Pathophysiology of obesity hypertension.

Authors:  J E Hall
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

3.  Cardiac remodeling in a rat model of diet-induced obesity.

Authors:  André Soares Leopoldo; Mário Matheus Sugizaki; Ana Paula Lima-Leopoldo; André Ferreira do Nascimento; Renata de Azevedo Melo Luvizotto; Dijon Henrique Salomé de Campos; Katashi Okoshi; Maeli Dal Pai-Silva; Carlos Roberto Padovani; Antonio Carlos Cicogna
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

4.  Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle.

Authors:  João Ferreira-Martins; Adelino F Leite-Moreira
Journal:  J Biomed Biotechnol       Date:  2010-06-02

Review 5.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

6.  Obesity preserves myocardial function during blockade of the glycolytic pathway.

Authors:  Dijon Henrique Salomé de Campos; André Soares Leopoldo; Ana Paula Lima-Leopoldo; André Ferreira do Nascimento; Silvio Assis de Oliveira-Junior; Danielle Cristina Tomaz da Silva; Mario Mateus Sugizaki; Carlos Roberto Padovani; Antonio Carlos Cicogna
Journal:  Arq Bras Cardiol       Date:  2014-09-12       Impact factor: 2.000

7.  Distinct genes and pathways associated with transcriptome differences in early cardiac development between fast- and slow-growing broilers.

Authors:  Jibin Zhang; Carl J Schmidt; Susan J Lamont
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

8.  Impact of body mass index on diastolic function in patients with normal left ventricular ejection fraction.

Authors:  W Aljaroudi; C Halley; P Houghtaling; S Agarwal; V Menon; L Rodriguez; R A Grimm; J D Thomas; W A Jaber
Journal:  Nutr Diabetes       Date:  2012-08-06       Impact factor: 5.097

9.  Chronic high-fat diet-induced obesity decreased survival and increased hypertrophy of rats with experimental eccentric hypertrophy from chronic aortic regurgitation.

Authors:  Wahiba Dhahri; Marie-Claude Drolet; Elise Roussel; Jacques Couet; Marie Arsenault
Journal:  BMC Cardiovasc Disord       Date:  2014-09-24       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.